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Background: The neuronal ceroid lipofuscinoses are heritable lysosomal storage diseases characterized by
progressive neurological impairment and the accumulation of autofluorescent storage granules in neurons and
other cell types. Various forms of human neuronal ceroid lipofuscinosis have been attributed to mutations in at
least 13 different genes. So far, mutations in the canine orthologs of 7 of these genes have been identified in
DNA from dogs with neuronal ceroid lipofuscinosis. The identification of new causal mutations could lead to the
establishment of canine models to investigate the pathogenesis of the corresponding human neuronal ceroid
lipofuscinoses and to evaluate and optimize therapeutic interventions for these fatal human diseases.
Case presentation: We obtained blood and formalin-fixed paraffin-embedded brain sections from a rescue dog
that was reported to be a young adult Chinese Crested. The dog was euthanized at approximately 19 months of
age as a consequence of progressive neurological decline that included blindness, anxiety, and cognitive impairment.
A diagnosis of neuronal ceroid lipofuscinosis was made based on neurological signs, magnetic resonance imaging of
the brain, and fluorescence microscopic and electron microscopic examination of brain sections. We isolated DNA from
the blood and used it to generate a whole genome sequence with 33-fold average coverage. Among the 7.2 million
potential sequence variants revealed by aligning the sequence reads to the canine genome reference sequence was a
homozygous single base pair deletion in the canine ortholog of one of 13 known human NCL genes: MFSD8:c.843delT.
MFSD8:c.843delT is predicted to cause a frame shift and premature stop codon resulting in a truncated protein, MFSD8:
p.F282Lfs13*, missing its 239 C-terminal amino acids. The MFSD8:c.843delT allele is absent from the whole genome
sequences of 101 healthy canids or dogs with other diseases. The genotyping of archived DNA from 1478 Chinese
Cresteds did not identify any additional MFSD8:c.843delT homozygotes and found only one heterozygote.
Conclusion: We conclude that the neurodegenerative disease of the Chinese Crested rescue dog was neuronal
ceroid lipofuscinosis and that homozygosity for the MFSD8:c.843delT sequence variant was very likely to be the
molecular-genetic cause of the disease.
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The neuronal ceroid lipofuscinoses (NCLs) are heritable
lysosomal storage diseases characterized by progressive
cognitive decline, motor impairment, vision loss, seizures,
and progressive brain atrophy together with the accumu-
lation of autofluorescent lysosomal storage bodies in the
brain, the retina and other tissues [1]. Human NCLs have
been attributed to mutations in at least 13 different genes
[2–15]. As indicated in Table 1, mutations in the canine
orthologs of 7 of these genes have been associated with
NCL in various dog breeds [16–24]. In addition, a neuro-
degenerative disease in American Staffordshire Terriers
with an ARSG mutation was initially described as an NCL
[25]; however, based on a recent description of Arsg-
knockout mice [26], the American Staffordshire Terrier
disease was more likely a mucopolysaccaridosis.
With written consent from the owner we obtained
blood and formalin-fixed brain tissue from a young adult
Chinese Crested that was euthanized due to progressive
neurological decline accompanied by brain atrophy. The
clinical signs suggested that neuronal ceroid lipofuscinosis
was the underlying disease. The fixed tissue was evaluated
for the presence of the autofluorescent storage material
that is characteristic of the NCLs. DNA was extracted
from the blood and used to generate a whole genome
sequence (WGS) which provided an opportunity to iden-
tify the disease-causing mutation.
Case presentation
An approximately 1.5-year-old, male neutered Chinese
Crested presented for disorientation, blindness and fearful
behavior. The dog had been adopted as a rescue at
approximately 4 months of age. The dog had always licked
compulsively. At about 1 year of age, he became with-
drawn, less playful, nervous, and fearful. One month priorTable 1 Human genes known to harbor NCL-causing mutation
Human disease Mutant gene Mutan
CLN1 PPT1 [2] Palmit
CLN2 TPP1 [3] Tripep
CLN3 CLN3 [4] CLN3
CLN4 DNAJC5 [5] DNAJC
CLN5 CLN5 [6] CLN5
CLN6 CLN6 [7,8] CLN6
CLN7 MFSD8 [9] MFSD8
CLN8 CLN8 [10] CLN8
CLN10 CTSD [11] Cathep
CLN11 GRN [12] Granul
CLN12 ATP13A2 [13] ATP13
CLN13 CTSF [14] Cathep
CLN14 KCTD7 [15] KCTD7to admission, he developed dilated pupils and began
bumping into objects. He also had episodes of behavioral
arrest. Ophthalmologic examination revealed an absent
menace response, a positive dazzle reflex, and a sluggish,
incomplete pupillary light reflex. Ocular exam revealed no
abnormalities, and an ERG was within normal limits.
Imaging of the brain was performed with a 1.5 T GE MRI
which included T2, FLAIR, GRE T1*, and T1 pre- and
post-contrast sequences. T2 weighted images showed a
lack of distinction between grey matter and white matter.
Enlarged ventricles and increased prominence of sulci of
the cerebrum and cerebellum suggested diffuse brain atro-
phy (Figure 1).
Over the next few weeks, the Chinese Crested became
more disoriented and stopped responding to the owner.
He would yelp in fear randomly and resisted being held.
He was sleeping more and developed pica. On presentation,
he was agitated and hyper-responsive to stimuli. He showed
a sensory ataxia in all 4 limbs, with normal proprioceptive
positioning. Other than the previously described ophthal-
mologic abnormalities, cranial nerves were normal, as were
the spinal reflexes. Cerebrospinal fluid analysis was within
normal limits. A progressive neurodegenerative disease was
suspected, and the dog was euthanized.
At necropsy, slices of the cerebellum and cerebral cortex
were fixed in formalin and embedded in paraffin for rou-
tine histological examination. Unstained sections of these
tissues were deparaffinized and examined with fluores-
cence microscopy as previously described [27]. Both the
cerebellum and the cerebral cortex exhibited massive
intracellular accumulations of autofluorescent material
with a golden yellow emission under blue light illumin-
ation (Figure 2). In the cerebellum storage material was
most prominent in the Purkinje cells, but substantial
amounts of this material were also present in the granulars and their orthologs known to cause NCL in dogs
t protein Canine disease described?
oyl-protein thioesterase 1 Yes [16]












Figure 1 T2 weighted MRI from the affected dog. In the sagittal
plane (A) prominent sulci in the cerebellum (asterisk) and the prominent
fourth ventricle below the cerebellum indicates atrophy. In the transverse
plane (B), prominent sulci in the cerebrum (arrows) and dilated lateral
ventricles (asterisks) indicate atrophy. The distinction between grey
matter and white matter in the remaining cerebral cortex is obscured.
Figure 2 Fluorescence micrographs of brain sections of
cerebellum (A and B) and cerebral cortex (C) demonstrating
the massive intracellular accumulation of yellow-emitting
autofluorescent storage bodies. In the cerebellum the storage
body accumulation was most pronounced in the Purkinje cells (arrows
in A and B). The section in (A) was cut perpendicular to the plane of
the Purkinje cell layer and the section in (B) was cut parallel to the
plane of the Purkinje cell layer. The storage body accumulation in the
neurons of the cerebral cortex was perinuclear and asymmetric. Bar in
(C) indicates the magnification for all 3 micrographs.
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autofluorescent storage granules were observed in
neurons throughout the cerebral cortex (Figure 2C).
Additional sections of the cerebellum were immuno-
stained for glial fibrillary acidic protein (GFAP) as pre-
viously described [28]. In the cerebellar medulla there
was a dramatic increase in GFAP staining intensity
with concentration of the staining in glial cell perinuclear
cytoplasm as well as in the cell processes (Figure 3A). By
comparison, GFAP staining in the cerebellar medulla from
a normal 12-month-old Beagle was much less intense and
was more diffuse (Figure 3B). The GFAP staining pattern
observed in the affected dog is characteristic of the
Figure 3 Micrographs of sections of the cerebellar medulla from the Chinese Crested with signs of neuronal ceroid lipofuscdinosis
(A) and from a normal 12-month-old Beagle (B). The sections were immunostained for GFAP (brown stain) and were counterstained with
hematoxylin (blue). Bar in (B) indicates the magnification of both micrographs.
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neuroinflammatory conditions [29,30].
To investigate the ultrastructural appearance of the
storage material, deparaffinized and rehydrated tissue
from the cerebellum was post-fixed in osmium tetroxide
and processed for electron microscopic examination
using established procedures [31]. The storage material
consisted primarily of aggregates of lamellar structures
organized in various patterns similar to those previously
described as fingerprint in appearance (Figure 4). How-
ever, none of the crystalline cross-hatched structures of
classical fingerprint inclusions characteristic of some
NCLs were seen [32].Figure 4 Electron micrographs of the storage material from cerebella
lamellar material that were condensed in some storage bodies (A) and moDNA was isolated from the blood as previously described
[20] and submitted to the University of Missouri DNA
Core Facility for library preparation and sequencing.
Two PCR-free paired-end libraries were created with
the Illumina TruSeq DNA PCR-Free Sample Prepar-
ation Kit. One had a fragment size of approximately
350 bp and the fragment size of the other was approxi-
mately 550 bp. Each library was sequenced on a flow-cell
lane of an Illumina HiSeq 2000 sequencer. The adaptors
were trimmed with custom Perl scripts and the adaptor-
trimmed reads were deposited in the Sequence Read
Archive (accession SRR1594157). MaSuRCA v2.2.2 soft-
ware [33] was used to error correct the adapter-trimmedr Purkinje cells. The storage bodies contained spherical aggregates of
re loosely organized in others (B).
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aligned to the CanFam3.1 reference genome assembly
with NextGENe software (SoftGenetics), which was also
used for the identification and initial categorization of
the sequence variants. Likely false positive variant calls
were identified and removed with custom Perl scripts.
The genome-wide average coverage was 33 fold. The
7.2 million potential sequence variants were uploaded
to a custom PostgreSQL database that also contained
the variant calls from another 101 canid WGSs. Forty-
three of these control WGSs were from our group and
58 were from others listed in the Acknowledgements.
Almost all of the NCLs are rare, recessively inherited
diseases, so we used an algorithm that identifies vari-
ants that were homozygous in the affected dog, absent
from the 101 control WGS and predicted to alter the
primary structure of the gene products. Sixty seven of
the sequence variants met these criteria (Additional
file 1: Table S1); however, none of them were from any
of the 13 known human NCL genes.
One of the 67 homozygous, unique, coding variants in
the Chinese Crested’s WGS was PCYOX1:c.1064C>T
(Figure 5A). This missense mutation predicts a p.T355I
amino acid substitution in the gene product, prenylcysteineFigure 5 Nucleotide sequence of NCL-affected Chinese Crested around
the WGS as presented by the NextGENe Viewer. Starting at the top the featur
PCYOX1), the codon number, the predicted amino acid sequence translated f
sequence translated from the aligned WGS reads, the genome-wide nucleotid
corresponding nucleotide sequence derived from the aligned WGS reads, and
or after the reads point in the directions that the reads were generated. N
aligned sequence are highlighted. In this case, a homozygous C>T transit
42 reads. (B) Automated Sanger sequencing confirmed the C>T transitionlyase. We considered PCYOX1:c.1064C>T to be a candidate
for causality because earlier investigators had predicted that
prenylcysteine lyase deficiencies might cause NCL [34].
Thus, we used flanking PCR primers 5’-TCTCCTGTTTAT
TATAGCAAG-3’ and 5’-TTTGAGAACATTGATATGCTT-
3’ to amplify and verify the sequence variant by automated
Sanger sequencing (Figure 5B). We next devised a TaqMan
allelic discrimination assay [35] to genotype archived DNA
samples at PCYOX1:c.1064C>T. For this assay the PCR
primers were 5’-CCATCAGTATTACCAACATATAGTGA
CAACT-3’ and 5’-GGTGGTTAAGATTGTACTGAGATC
GA-3’ and the competing probes were 5’-VIC-AGCTAA
AAAGAATTGAATTC-MBG-3’ (variant allele) and 5’-FAM-
AGCTAAAAAGAGTTGAATTC-MBG-3’ (reference allele).
We used this assay to genotype archived samples from 325
randomly selected Chinese Cresteds and found that 219
samples were homozygous for the reference c.1064C allele,
86 samples were heterozygous and 20 samples were
homozygous for the variant c.1064T allele. Thus, the T
allele frequency for this random cohort of Chinese
Cresteds was 0.19 – much higher than would be expected
if c.1064T homozygosity were the cause of this rare NCL.
A check of the clinical records indicated that 2 of the
c.1064T homozygotes were over 10 years old andPCYOX1:c.1064C > T. (A) Shows the alignment of sequence reads from
es include the nucleotide coordinates on CFA10, the gene (in this case
rom the canine genome reference sequence, the predicted amino acid
e coordinates, the regional reference canine genome sequence, the
the sequences of the individual reads. The symbols “>” and “<” before
ucleotide differences between the reference sequence and the
ion that predicts a T355I amino acid substitution is supported by
.
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unlikely that the PCYOX1:c.1064T allele causes or contrib-
utes to the Chinese Crested’s NCL. This conclusion is
consistent with a report that nullizygous Pcyox1 knockout
mice do not show clinical signs of disease [36].
Because a plausible relationship between NCL and the
other homozygous, unique, coding variants was not appar-
ent, we tried a different strategy for mutation discovery.
We used the NextGENeViewer to observe the Chinese
Crested alignment and identified sequence variants by
scanning through all 130 coding exons in the canine
orthologs of the 13 genes associated with human NCLTable 2 Homozygous variants in the coding exons of NCL gen
Gene Exons with no variants Variants
Exon cDNA
TPP1 1-6, 8-12 7 c.711A
7 c.885C
PPT1 1-9





CLN6 2,3,5-7 1 c.86A>
4 c.327G
MFSD8 1-7,9-12 8 c.846d
CLN8 2 1 c.327A
CTSD 1-9
GRN 1-9,11 10 c.1326
CTGC















CTSF 2-13 1 c.169A
KCTD7 1-4(Table 1). The results are summarized in Table 2. No vari-
ants were found in the coding exons of PPT1, DNAJC5,
CLN5, CTSD, or KCTD7. In and around the coding exons
of the other 8 candidate genes, we found 26 sequence
variants including 14 synonymous mutations that are
unlikely to cause disease. In addition, we found 6 missense
mutations, 4 intronic variants within 8 bp of an exon
where they could affect exon splicing, one complex
deletion-insertion that results in the deletion of 7 codons
and the insertion of 2 codons, and a single-base deletion
and frame shift. The missense mutations, the intronic var-
iants and the complex deletion-insertion were all commones in the WGS of the Chinese Crested with NCL
change A.A. change Comment
>G p.A237A Silent mutation
>T p.P295P Silent mutation
>G p.E70G Common allele
-3 T>C Common allele
C>T p.L437L Silent mutation
G p.R29K Common allele
>T p.L109L Silent mutation
elT p.F282fs Unique allele
>G p.T109T Silent mutation
_1344delins p.LPPAPTH 442_448FC Common allele
>A p.A70T Common allele
>G p.H170R Common allele
8A>G Common allele
>T p.D213D Silent mutation
>G p.R242R Silent mutation
>C p.M243T Common allele
>C p.Y297Y Silent mutation
T>C p.P402P Silent mutation
-8_-6TCT> CCG Common allele
T>C p.Y564Y Silent mutation
+5_+8CCCT> GCTG Common allele
>TC p.L1004L Silent mutation
C>T p.F1040F Silent mutation
A>G p.A1052A Silent mutation
A>G p.M255V Common allele
>C p.R57R Silent mutation
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unrelated diseases and thus are unlikely to cause the
Chinese Crested’s rare NCL. In contrast MFSD8:c.843delT,
the single-base deletion and frame shift, occurred as a
homozygous sequence variant in the affected Chinese, but
was absent from the 101 control WGSs in our data set.
Figure 6A shows the affected Chinese Crested alignment
around MFSD8:c.843delT. This sequence variant was fil-
tered from our earlier search for unique, homozygous,
coding variants because it was classified as a heterozygous
variant. Visual inspection of the alignment indicated that
one of three consecutive deoxythymidines (or Ts) was
deleted. For all reads that spanned this TTT segment the
alignment algorithm positioned the deletion at the third
(or 3’ most) T. However, 1 read was initiated within the
TTT region and extended in the 3’ direction and another
read was initiated from the 3’ direction and ended within
the TTT region. Both of these reads could be perfectly
aligned to the reference sequence with a T at position
MFSD8:c.843, so the NextGENe software classified the
variant at this position as a heterozygous T deletion. In
our experience, homozygous partial deletions of tandem
repeats have often been misclassified as heterozygous. We
now recognize these errors because the reads supporting
the deletion alleles are much more numerous than the
reads supporting the reference sequence alleles.
MFSD8:c.843delT was predicted to encode MFSD8:p.
F282Lfs13*, a truncated variant of the gene product,Figure 6 Nucleotide sequence of NCL-affected Chinese Crested aroun
alignment of WGS reads around MFSD8:c.843delT. All 30 reads that span the
deletion. The read that is the third from the top starts within the TTT sequ
Because these 2 reads aligned with a T at the position corresponding to M
heterozygous T deletion. (B) Automated Sanger sequencing indicated thatMSFD8. MFSD8 is member 8 in the family of mammalian
major facilitator superfamily (MFS) domain-containing
proteins. The MFS domain consists of 12 transmembrane
helices. Although the function of MFSD8 has not been
established, other MFS domain-containing proteins trans-
port a diverse variety of substances across biomembranes
[37]. MFSD8 is expressed throughout the body [9]. An
N-terminal dileucine motif targets the MFSD8 protein
to lysosomal membranes [38,39] where it may control
the passage of unknown substrates into or out of the
lysosomes. The MFSD8:p.F282Lfs13* frame shift was
predicted to occur within the 7th transmembrane helix
and would delete 239 C-terminal codons. The resulting
truncated protein would lack the 5 C-terminal trans-
membrane helices of the MFS domain and thus be very
unlikely to retain function.
In 2007, MFSD mutations were first reported to cause
a subtype of human NCL [9], now referred to as CLN7.
Since then, a total of at least 22 MFSD mutations have
been identified in CLN7 patients [40–43]. In most CLN7
patients, the initial signs occurred between 2 and 5 years
of age. Typically, the initial signs were one or more of
the following: developmental delay or regression, stereo-
typed hand movements, seizures, ataxia, and loss of
vision. The disease progressed rapidly and most CLN7
patients exhibited myoclonus and mental regression and
became wheelchair bound before their 7th birthday.
Serial magnetic resonance images from one CLN7 patientdMFSD8:c.843delT. (A) Shows the NextGENe Viewer display of the
3 consecutive Ts that make up codon 282 show a highlighted 1 bp
ence and the read at the bottom ends within the TTT sequence.
FSD8:c.843, the NextGENe software scored the variant at C.843 as a
the NCL-affected Chinese Crested had a homozygous T deletion.
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Most CLN7 patients have died before their 13th birthday
[9,40–43]. The vision loss, ataxia, brain atrophy, and
cognitive decline in the Chinese Crested were comparable
to the signs reported in children. These signs, however,
were not apparent until the dog reached young adulthood.
Nonetheless, the earlier onset of excessive licking may
have been comparable to the stereotyped hand move-
ments reported in children. No seizures or myoclonus
were reported in the dog. Seizures and myoclonus occur
late in the course of disease in other canine NCLs
[17,23,44], and the Chinese Crested may have been eutha-
nized before those signs would have developed.
A recent report described the creation and charac-
terization of an Mfsd8 knockout mouse model [45]. The
Mfsd8 nullizygous mice had a depletion of retinal photo-
receptors and an accumulation of neuronal autofluores-
cent storage bodies. The ultrastructural appearance of the
storage material in these mice was similar to that observed
in the affected Chinese Crested dog. However, unlike the
human CLN7 patients and our dog, the Mfsd8 nullizygous
mice did not exhibit any neurologic signs, behavior
changes, brain atrophy or premature death [45].
We were eager to confirm our findings in other dogs
and, if possible, to establish an MFSD8-deficient animal
model that, like the human CLN7 patients, develops neu-
rodegeneration and progressive neurological impairment.
We, therefore, devised a TaqMan allelic discrimination
assay to genotype archived DNA samples at MFSD8:c.843.
The PCR primers for this assay were 5’-CTGTTG
TGGCCACTAATATTGTGTT-3’ and 5’-TGAAGACAGAA
TAAAACTTACGTTTCAAAAAGG-3’ and the competing
probes were 5’-VIC-CGTGATTCTATTATCTTTG-MBG-
3’ (variant allele) and 5’-FAM-CGTGATTCTATTTATCT
TTG-MBG-3’ (reference allele). With this assay we
genotyped archived DNA samples from 1,478 Chinese
Cresteds. All but one of these samples were homozygous
for the reference MFSD8:c.843T allele. A single sample
was heterozygous for c.843delT. That sample was obtained
for an unrelated analysis in 2010 from a 10-year-old
Chinese Crested that lived in Sweden. This indicates
that although the mutant allele is rare, it has a wide-
spread geographic distribution.
Conclusions
Based on the clinical neurological signs, the brain atrophy,
the massive accumulation of autofluorescent storage
bodies in the brain, and the lamellar ultrastructure of
the material within the storage bodies, we conclude
that the Chinese Crested’s disease should be classified
as an NCL. Also, we conclude that the homozygous
MFSD8:c.843delT deletion is very likely to be the molecu-
lar genetic cause of this NCL. The second conclusion was
reached because a variety of mutations in the humanortholog have caused a clinically similar disease in CLN7
patients and because the deletion of c.843T creates a
frame shift predicted to cause the mutant gene to encode
a severely truncated protein without function.
Because the MFSD8:c.843delT allele appears to be quite
rare even among Chinese Cresteds, we do not believe that
commercial DNA testing for the deletion is warranted.
Nonetheless, the identification of additional MFSD8:
c.843delT homozygous dogs with NCL would be strong
added support that this deletion can cause recessive
canine NCL. Furthermore, if reproductively intact dogs
with this deletion could be identified, they could be the
foundation for a research colony to provide an animal
model with a disease phenotype that mirrors CLN7 more
closely than the current homozygous Mfsd8 knockout
mouse. The potential value of canine NCL models is illus-
trated by the canine model for human CLN2 [17,27,46].
Preclinical studies using this model served as the basis for
an ongoing human clinical trial of enzyme replacement
therapy [47]. We have described a distinct young-adult-
onset neurodegenerative disease of Chinese Cresteds [48]
and have used whole-genome sequencing to identify its
molecular genetic cause (manuscript in preparation). If
veterinarians or researchers have access to unexplained
cases of neurodegenerative diseases of Chinese Cresteds
(or dogs of other breeds), we would like to help establish
molecular genetic diagnoses.
Additional file
Additional file 1: Table S1. Homozygous, unique coding variants in
whole genome sequence of Chinese Crested with NCL.
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